Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0/box
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg
  • Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg
  • Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg
  • Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg
  • Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg
  • Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg
Find Similar Products
  • Overview
  • Company Profile
Overview

Basic Info.

Model NO.
AMC12005
Suitable for
Elderly, Children, Adult
State
Solid
Shape
Tablet
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Function
Antimalarial
Standard Available
Bp, Cp
Delivery Time
30~60 Days
OEM/ODM
Support
Transport Package
6′ S/Box
Specification
80+480MG
Trademark
Medipharm, OEM
Origin
China
HS Code
3003601000
Production Capacity
1000000 Boxes/Month

Product Description

Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mg

ARTEMETHER+LUMEFANTRINE TABLET 80+480mg

Indications:

This medication is used to treat malaria in adults and children. The two ingredients in this medication belong to a class of drugs known as antimalarials. Malaria is an infection caused by mosquito bites received while traveling or living in regions of the world where malaria is common. Malaria parasites enter the body, and live in body tissues such as red blood cells or the liver. This medication is used to kill the malaria parasites living inside red blood cells. In some cases, you may need to take a different medication (such as primaquine) to kill the malaria parasites living in the liver. Both treatments may be needed for a complete cure and to avoid the return of infection (relapse). This product is not used to prevent malaria.

Dosage and Administration:

Take this medication by mouth, with food, exactly as prescribed by your doctor. This medication is usually taken twice a day with a meal for 3 days (6 doses) or as directed by your doctor. On your first day of treatment, take your first dose with food, followed by your second dose 8 hours later. Then each day for the next 2 days, take one dose in the morning and one dose in the evening.

Precautions & Warning:

Before taking artemether/lumefantrine, tell your doctor or pharmacist if you are allergic to artemether or lumefantrine; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: recent use (within the past month) of any medication to prevent or treat malaria (such as halofantrine, quinine, or quinidine), kidney problems, liver problems.

Artemether/lumefantrine may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.

Older adults may be more sensitive to the side effects of this drug, especially QT prolongation.

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is unknown if this medication passes into breast milk. Consult your doctor before breast-feeding.

Contra-indications:

Hypersensitivity to Artemether, Lumefantrine or any of the excipients in the finished product.

Drug interactions:

CYP3A4 Inhibitors: Use cautiously due to potential for QT prolongation.

Mefloquine: If used immediately before treatment, monitor for decreased effcacy of Coartem Tablets and encourage food consumption

Hormonal Contraceptives: Effectiveness may be reduced; use an additional method of birth control

Anti-Retrovirals: Usc cautiously due to potential for QT prolongation, loss of anti-viral effcacy, or loss of antimalarial effcacy of Coartem Tablets.

CYP2D6 Substrates: Monitor for adverse reactions and potential QT prolongation

Storage instructions:

Do not store above 30°C.

Testing terms Standards Results
Characters yellowish tablets yellowish tablets
Uniformity of weight ±7.5% 2.8%
friability No fractures, cracks or shredded pieces were detected, and
the weight loss did not exceed 1%
0.32%
Dissolution Artemether   1h  Limit:Min  30%  3h  Limit:Min  50%
Benfluorenol   Limit: Min 50%
1h:58.11%
3h:65.66%
81.01%
Microbial Limit Test Passed Test Passed
Assay Ci6H26O5 Limit:  90~110% 
C30H32Cl3NO Limit:  90~110%
102.90%
97.55%
Company Profile

Antimalarials GMP Artemether+Lumefantrine Tablet 80+480mgAntimalarials GMP Artemether+Lumefantrine Tablet 80+480mgAntimalarials GMP Artemether+Lumefantrine Tablet 80+480mgAntimalarials GMP Artemether+Lumefantrine Tablet 80+480mgAntimalarials GMP Artemether+Lumefantrine Tablet 80+480mgAntimalarials GMP Artemether+Lumefantrine Tablet 80+480mg

 



 




 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier